Cargando…
A Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study
Autores principales: | Cohen, Stanley, Akmaev, Viatcheslav R., Withers, Johanna B., Connolly-Strong, Erin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814066/ https://www.ncbi.nlm.nih.gov/pubmed/34757533 http://dx.doi.org/10.1007/s40744-021-00387-9 |
Ejemplares similares
-
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study
por: Cohen, Stanley, et al.
Publicado: (2021) -
Response letter regarding the letter to the editors by Brown et al.
por: Taylor, Sylvia, et al.
Publicado: (2016) -
Response to letter to editor regarding Seizure‐precipitating factors in dogs with idiopathic epilepsy
por: Forsgård, Johanna, et al.
Publicado: (2019) -
Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility
por: Arnell, Christopher, et al.
Publicado: (2021) -
Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)
por: Annovazzi, Pietro, et al.
Publicado: (2018)